New Fund
Closed KP22 ($1B early-stage) and KP Select IV ($2.5B growth) for total of $3.5B, targeting AI companies across stack and real economy.
KP22 and KP Select IV
MAR 24, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
KP22 and KP Select IV
Harvey
Garner Health
Lotus Health AI
Motive
Harvey
appliedintuition.com